Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine

被引:0
|
作者
Akira Hata
Yoshihiro Onouchi
机构
[1] Graduate School of Medicine,Department of Public Health
[2] Chiba University,undefined
[3] Laboratory for Cardiovascular Diseases,undefined
[4] Center for Genomic Medicine,undefined
来源
Journal of Human Genetics | 2009年 / 54卷
关键词
coronary artery legions; inositol 1,4,5-trisphosphate 3-kinase C; Kawasaki's disease; personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
Kawasaki disease (KD) is an acute systemic vasculitis syndrome, which primarily affects in children under the age of 5 years. In 20–25% of cases, if untreated, coronary artery lesions develop, making KD the leading cause of acquired heart disease in children in both Japan and the United States. Since 1970, 19 nationwide surveys of KD in Japan have been conducted every 2 years and the data are stored in a database. Even though the etiology of KD remains unknown, despite enthusiastic research spanning more than 40 years, we have learnt a great deal about KD from this enormous database. These 19 epidemiologic studies indicate a strong genetic influence on the disease susceptibility, prompting us and other researchers to identify the responsible genes for KD by applying either the candidate gene approach or the genome-wide approach. We have employed a genome-wide linkage study using affected sibling pair data of KD in Japan and have identified several susceptibility loci. Further analysis focusing on a region of chromosome 19, where one of the linked loci was detected, identified a predisposing gene, which codes inositol 1,4,5-trisphosphate 3-kinase C (ITPKC). In this review, we summarize the cumulative knowledge regarding KD, and then outline our hypothesis of the role ITPKC plays in KD susceptibility and our trial that aims toward the implementation of personalized medicine for KD.
引用
收藏
页码:67 / 73
页数:6
相关论文
共 50 条
  • [31] Echocardiographic Endophenotypes of Chronic Obstructive Pulmonary Disease: A Step toward Personalized Medicine
    Freed, Benjamin H.
    Thenappan, Thenappan
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211 (03) : 426 - 427
  • [32] Tendency toward atopy in Kawasaki disease
    Matsuoka, S
    Tatara, K
    Nakagawa, R
    Mori, K
    Kuroda, Y
    EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (01) : 30 - 32
  • [33] Toward Personalized Medicine in the Pharmacotherapy of Alcohol Use Disorder: Targeting Patient Genes and Patient Goals
    Batki, Steven L.
    Pennington, David L.
    AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (04): : 391 - 394
  • [34] Pharmacogenomics in osteoporosis: Steps toward personalized medicine
    Greene, Robert
    Mousa, Shaymaa S.
    Ardawi, Mohamed
    Qari, Mohamed
    Mousa, Shaker A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2009, 2 : 69 - 78
  • [35] Telomere Profiling: Toward Glioblastoma Personalized Medicine
    Sylvain Ferrandon
    Paul Saultier
    Julien Carras
    Priscillia Battiston-Montagne
    Gersende Alphonse
    Michael Beuve
    Céline Malleval
    Jérôme Honnorat
    Tania Slatter
    Noelyn Hung
    Janice Royds
    Claire Rodriguez-Lafrasse
    Delphine Poncet
    Molecular Neurobiology, 2013, 47 : 64 - 76
  • [36] The Roadmap toward Personalized Medicine: Challenges and Opportunities
    Cinti, Caterina
    Trivella, Maria Giovanna
    Joulie, Michael
    Ayoub, Hussein
    Frenzel, Monika
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (06):
  • [37] Toward Personalized Exercise Medicine: A Cautionary Tale
    Brennan, Andrea M.
    Day, Andrew G.
    Clarke, John
    Ross, Robert
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (11) : 1861 - 1868
  • [38] Toward Personalized Sexual Medicine: Where is the Evidence?
    Leusink, Peter
    Boeke, A. Joan P.
    Laan, Ellen
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 (09): : 2357 - 2358
  • [39] The computable cell: A step toward personalized medicine
    Gough, Nancy R.
    SCIENCE SIGNALING, 2015, 8 (408)
  • [40] Toward personalized medicine in patients with familial hypercholesterolemia
    Tada, Hayato
    Takamura, Masayuki
    ATHEROSCLEROSIS, 2024, 397